申请人:Industry Foundation of Chonnam National University
公开号:EP3816156A1
公开(公告)日:2021-05-05
The present invention relates to a radioactive compound with improved targeting ability for melanoma and a pharmaceutical composition for the treating melanoma comprising the same, and the targeting ability for melanoma is improved as compared to the conventional contrast agent for melanoma. The radioactive compound according to an embodiment of the present invention shows a very excellent therapeutic effect on melanoma.
本发明涉及一种对黑色素瘤具有更强靶向能力的放射性化合物,以及包含该化合物的治疗黑色素瘤的药物组合物,与传统的黑色素瘤造影剂相比,本发明提高了对黑色素瘤的靶向能力。根据本发明的一个实施方案,放射性化合物对黑色素瘤有非常好的治疗效果。